OBJECTIVES: Biliary atresia (BA) is a rapidly progressive form of biliary fibrosis affecting neonates. We previously reported that primary cilia on the intrahepatic cholangiocytes of patients with both syndromic and nonsyndromic BA were structurally abnormal. Our objective was to determine whether extrahepatic cholangiocytes in human biliary atresia, intrahepatic and extrahepatic cholangiocytes of rhesus rotavirus (RRV)-infected neonatal mice, and RRV-infected primary neonatal extrahepatic cholangiocytes also demonstrate ciliary abnormalities. METHODS: The livers of neonatal BALB/c mice injected with RRV that developed jaundice, human extrahepatic bile duct samples obtained at time of hepatoportoenterostomy, and RRV-infected primary neonatal cholangiocytes were stained with antibodies against acetylated α tubulin to identify primary cilia. RESULTS: Extrahepatic cholangiocytes from RRV-treated mice demonstrated minimal loss of primary cilia at day 3 but almost complete loss at day 8 and partial loss at day 12. No changes were seen in mouse intrahepatic bile ducts at any of the time points. In the human BA samples, primary cilia were almost completely absent from extrahepatic duct cholangiocytes. There were, however, abundant cilia in the peribiliary glands adjacent to extrahepatic ducts in the BA sample. Cilia in RRV-infected primary neonatal cholangiocytes were significantly decreased compared with controls. CONCLUSIONS: Primary cilia are selectively lost from neonatal extrahepatic but not intrahepatic cholangiocytes after RRV infection in BALB/c mice. The cilia are also decreased in RRV-infected primary cholangiocytes and the extrahepatic ducts from human patients with BA. This suggests that ciliary abnormalities are part of the pathophysiology of BA.
OBJECTIVES:Biliary atresia (BA) is a rapidly progressive form of biliary fibrosis affecting neonates. We previously reported that primary cilia on the intrahepatic cholangiocytes of patients with both syndromic and nonsyndromic BA were structurally abnormal. Our objective was to determine whether extrahepatic cholangiocytes in humanbiliary atresia, intrahepatic and extrahepatic cholangiocytes of rhesus rotavirus (RRV)-infected neonatal mice, and RRV-infected primary neonatal extrahepatic cholangiocytes also demonstrate ciliary abnormalities. METHODS: The livers of neonatal BALB/c mice injected with RRV that developed jaundice, human extrahepatic bile duct samples obtained at time of hepatoportoenterostomy, and RRV-infected primary neonatal cholangiocytes were stained with antibodies against acetylated α tubulin to identify primary cilia. RESULTS: Extrahepatic cholangiocytes from RRV-treated mice demonstrated minimal loss of primary cilia at day 3 but almost complete loss at day 8 and partial loss at day 12. No changes were seen in mouse intrahepatic bile ducts at any of the time points. In the human BA samples, primary cilia were almost completely absent from extrahepatic duct cholangiocytes. There were, however, abundant cilia in the peribiliary glands adjacent to extrahepatic ducts in the BA sample. Cilia in RRV-infected primary neonatal cholangiocytes were significantly decreased compared with controls. CONCLUSIONS: Primary cilia are selectively lost from neonatal extrahepatic but not intrahepatic cholangiocytes after RRV infection in BALB/c mice. The cilia are also decreased in RRV-infected primary cholangiocytes and the extrahepatic ducts from humanpatients with BA. This suggests that ciliary abnormalities are part of the pathophysiology of BA.
Authors: Bing Q Huang; Tatyana V Masyuk; Melissa A Muff; Pamela S Tietz; Anatoliy I Masyuk; Nicholas F Larusso Journal: Am J Physiol Gastrointest Liver Physiol Date: 2006-09 Impact factor: 4.052
Authors: Barrett H Barnes; Rebecca M Tucker; Fabian Wehrmann; Doug G Mack; Yoshiyuki Ueno; Cara L Mack Journal: Liver Int Date: 2008-11-15 Impact factor: 5.828
Authors: Anatoliy I Masyuk; Sergio A Gradilone; Jesus M Banales; Bing Q Huang; Tatyana V Masyuk; Seung-Ok Lee; Patrick L Splinter; Angela J Stroope; Nicholas F Larusso Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-08-07 Impact factor: 4.052
Authors: Kristin Lorent; Weilong Gong; Kyung A Koo; Orith Waisbourd-Zinman; Sara Karjoo; Xiao Zhao; Ian Sealy; Ross N Kettleborough; Derek L Stemple; Peter A Windsor; Stephen J Whittaker; John R Porter; Rebecca G Wells; Michael Pack Journal: Sci Transl Med Date: 2015-05-06 Impact factor: 17.956
Authors: Adrian P Mansini; Estanislao Peixoto; Kristen M Thelen; Cesar Gaspari; Sujeong Jin; Sergio A Gradilone Journal: Biochim Biophys Acta Mol Basis Dis Date: 2017-06-15 Impact factor: 5.187
Authors: John-Paul Berauer; Anya I Mezina; David T Okou; Aniko Sabo; Donna M Muzny; Richard A Gibbs; Madhuri R Hegde; Pankaj Chopra; David J Cutler; David H Perlmutter; Laura N Bull; Richard J Thompson; Kathleen M Loomes; Nancy B Spinner; Ramakrishnan Rajagopalan; Stephen L Guthery; Barry Moore; Mark Yandell; Sanjiv Harpavat; John C Magee; Binita M Kamath; Jean P Molleston; Jorge A Bezerra; Karen F Murray; Estella M Alonso; Philip Rosenthal; Robert H Squires; Kasper S Wang; Milton J Finegold; Pierre Russo; Averell H Sherker; Ronald J Sokol; Saul J Karpen Journal: Hepatology Date: 2019-03-21 Impact factor: 17.425
Authors: Michelle A Estrada; Xiao Zhao; Kristin Lorent; Alyssa Kriegermeier; Seika A Nagao; Simon Berritt; Rebecca G Wells; Michael Pack; Jeffrey D Winkler Journal: ACS Med Chem Lett Date: 2017-12-14 Impact factor: 4.345